Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept

por Dervieux, Thierry, Kremer, Joel M, Weinblatt, Michael E
Publicado 2019

A Model to Predict Future Biologic or Targeted Synthetic DMARD Switch at a Subsequent Clinic Visit in Rheumatoid Arthritis

por Cappelli, Laura C., Reed, George, Pappas, Dimitrios A., Kremer, Joel M.
Publicado 2023

External Validation of a Risk Score for Major Toxicity Among Nonsteroidal Anti‐Inflammatory Drug Users: Real‐World Application

por Solomon, Daniel H., Paynter, Nina P., Guan, Hongshu, Kremer, Joel M.
Publicado 2020

Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measures

por Kremer, Joel M, Lawrence, David A, Hamilton, Robert, McInnes, Iain B
Publicado 2016

Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis

por Harrold, Leslie R., Reed, George W., Best, Jennie, Zlotnick, Steve, Kremer, Joel M.
Publicado 2018

“Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients”

por Pappas, Dimitrios A, Kremer, Joel M, Reed, George, Greenberg, Jeffrey D, Curtis, Jeffrey R
Publicado 2014

Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics

por Kremer, Joel M, Schiff, Michael, Muram, David, Zhong, Jinglin, Alam, Jahangir, Genovese, Mark C
Publicado 2018

Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry

por Pappas, Dimitrios A., Blachley, Taylor, Zlotnick, Steve, Best, Jennie, Emeanuru, Kelechi, Kremer, Joel M.
Publicado 2020

TNFi Cycling Versus Changing Mechanism of Action in TNFi‐Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study

por Curtis, Jeffrey R., Kremer, Joel M., Reed, George, John, Ani K., Pappas, Dimitrios A.
Publicado 2021

Tofacitinib in Combination With Conventional Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient‐Reported Outcomes From a Phase III Randomiz...

por Strand, Vibeke, Kremer, Joel M., Gruben, David, Krishnaswami, Sriram, Zwillich, Samuel H., Wallenstein, Gene V.
Publicado 2017

Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice

por Pappas, Dimitrios A., Etzel, Carol J., Zlotnick, Steve, Best, Jennie, Blachley, Taylor, Kremer, Joel M.
Publicado 2019

Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey

por Pappas, Dimitrios A., Brittle, Christine, Concoff, Andrew, Holman, Andrew J., Takasugi, Dennis, Kremer, Joel M.
Publicado 2022

Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry

por Pappas, Dimitrios A., Kremer, Joel M., Griffith, Jenny, Reed, George, Salim, Bob, Karki, Chitra, Garg, Vishvas
Publicado 2017

Hydroxychloroquine and the risk of respiratory infections among RA patients

por Kremer, Joel M, Reed, George, Pappas, Dimitrios A, Harold, LR, Kane, Kevin, Greenberg, Jeffrey, Winthrop, Kevin
Publicado 2020

The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry

por Padula, Anthony S., Pappas, Dimitrios A., Fiore, Stefano, Blachley, Taylor S., Ford, Kerri, Emeanuru, Kelechi, Kremer, Joel M.
Publicado 2022

Integrated safety in tocilizumab clinical trials

por Schiff, Michael H, Kremer, Joel M, Jahreis, Angelika, Vernon, Emma, Isaacs, John D, van Vollenhoven, Ronald F
Publicado 2011

Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry

por Mease, Philip J, Collier, David H, Saunders, Katherine C, Li, Guo, Kremer, Joel M, Greenberg, Jeffrey D
Publicado 2015

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis

por Kavanaugh, Arthur, Singh, Rakesh, Karki, Chitra, Etzel, Carol J., Kremer, Joel M., Greenberg, Jeffrey D., Griffith, Jenny
Publicado 2018

Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study

por Pappas, Dimitrios A., Brittle, Christine, Mossell, James E., Withers, Johanna B., Lim-Harashima, Jeraldine, Kremer, Joel M.
Publicado 2020

Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necro...

por Harrold, Leslie R., Reed, George W., Magner, Robert, Shewade, Ashwini, John, Ani, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2015